Condition
Ataxia, Spinocerebellar
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 2 (1)
Trial Status
Completed3
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07250321Not ApplicableActive Not Recruiting
Efficacy of tDCS in Degenerative Ataxia
NCT07136844Not ApplicableRecruiting
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NCT07079332Not Yet Recruiting
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
NCT04740359Not ApplicableCompletedPrimary
Functional Trunk Training in Ataxia Patients
NCT05038306Phase 2CompletedPrimary
Chinese Medicine WT for Spinocerebellar Ataxia Type 3
NCT03120013Not ApplicableCompleted
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
Showing all 6 trials